Clinical Trial

Cranberry and Gut Health in Crohn's Disease

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is investigating whether a cranberry-based dietary supplement, rich in polyphenols and fiber, can enhance gut health in individuals with Crohn's disease. People with Crohn's disease often have an imbalance in their gut microbiome (the community of bacteria in the gut). Previous research suggests that cranberry compounds may help support beneficial gut bacteria. In this study, adults with Crohn's disease will be randomly assigned to one of two groups: one group will receive a cranberry supplement to take once daily for 10 weeks, and the other group will receive a placebo (a supplement with no active ingredients). All participants will be asked to complete online questionnaires and collect samples of their blood, urine, and stool at four time points over a total of 15 weeks. These samples will help researchers understand how the cranberry supplement affects the gut microbiome, inflammation, and overall health. Participation is voluntary, and participants can withdraw from the study at any time. The results of this study may help identify new diet-based approaches to improve gut health in individuals with Crohn's disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-11; most recent amendment 2026-07-17.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07170462
Lead Sponsor Ana Maldonado-Contreras
Conditions Crohn Disease (CD), Crohn Disease
Enrollment 50 participants
Start Date 2025-10-29
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-20